Tag: Merck

The Merck Group, branded and commonly known as Merck, is a German multinational chemical, pharmaceutical and life sciences company headquartered in Darmstadt, with around 50,000 employees in around 70 countries. Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.

MSD acquires an Australian biotechnology company

Merck and Viralytics Limited announced that the companies have signed a definitive agreement under which Merck will acquire Viralytics, an Australian company focused on oncolytic immunotherapy treatments for a range of cancers.

Merck will buy Rigontec to firm up its leadership in immuno-oncology

Merck, known as MSD, and Rigontec today announced that Merck will acquire Rigontec

Merck KGaA will colaborate with F-star on cancer immunotherapy

Merck, a leading science and technology company, announced a new strategic collaboration with biopharmaceutical company F-star

Merck entered a worldwide license agreement with Teijin Pharma

Merck announced that it has entered into an exclusive worldwide license agreement with Teijin Pharma

China regulators approved HPV vaccine by Merck

China’s drug regulators have approved the commercial sale of Merck & Co.’s vaccine that protects against the human papillomavirus (HPV)

Merck starts new collaboration centre in India

Merck, a leading science and technology company across life sciences, healthcare, and performance materials, has announced the expansion of its M Lab Collaboration Centre in Bangalore, India.

Merck aquired Grzybowski Scientific Inventions company

merck kgaa
Merck, a leading science and technology company, announced the acquisition of Grzybowski Scientific Inventions (GSI), a company that developed the revolutionary computer-aided retro-synthesis tool, Ch...

Merck sold its biosimilars business to Fresenius

merck kgaa
Merck has divested its biosimilars business to German company Fresenius in a deal potentially worth 670 million euros. The move is aligned with a strategy of focusing on innovative medicines while ena...

Merck and Far Eastern Federal University established strategic partnership

Far Eastern Federal University (FEFU); Merck, a science and technology company engaged in health care, life science, production of high-tech materials; and FEFU Foundation have signed a tripartite mem...

FDA approved Merck’s pembrolizumab

Merck / MSD announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab), the company’s anti-PD-1 (programmed death receptor-1) therapy, for the treatment of a...

Merck antiviral medicine prevents serious infection after marrow transplant

Merck & Co., known as MSD, announced results of the pivotal Phase 3 clinical study of letermovir, an investigational antiviral medicine for the prevention of clinically-significant cytomegalovirus...

The first Immuno-Oncology Drug of the Innovative PD-1 Inhibitor Class has been Approved in Russia

MSD, known as Merck & Co. in the United States and Canada, informs that the first-in-class of the PD-1 inhibitors immuno-oncology drug, pembrolizumab, has been approved in Russia. This drug is ind...

MSD and Akrikhin co-invest 300 million rubles in innovative medicines production

Companies aim to expand and deepen partnership in the transfer of pharmaceutical technologies MSD, a global healthcare company known as Merck & Co., Inc. in the U.S. and Canada, and the leading...